Post by
Duster340 on Jan 19, 2024 3:52pm
also 🚩
i think a lot of those newly issued shares are not even tradeable yet. but they will be next week
Comment by
Montana5 on Jan 19, 2024 4:34pm
So you exercise your warrants at a dollar and then try to sell them for a loss?? Doesn't make sense. The selling we are seeing now is due to frustration more than anything else. The dilutive effect is irrelevant as it is really about the success of Otena vs the survival of this company.
Comment by
Montana5 on Jan 21, 2024 7:53pm
A successful P2 for acute will likely move the share price to at least $2.50 for ATE to consider another equity issue. It would help self fund P3 and other potential developments (clinically and corporate).
Comment by
Benedictus on Jan 30, 2024 12:46am
Thanks Mugs, appreciate your perspective as always. Should be an exciting year!